| 1 | Receive the Annual Report | For |
| 2 | Approve the Interim Dividends: USD 1.03 and 2.17 | For |
| 3 | Appoint the Auditors, KPMG | For |
| 4 | Allow the Board to Determine the Auditor's Remuneration | For |
| 5a | Re-elect Michel Demaré - Chair (Non Executive) | Oppose |
| 5b | Re-elect Pascal Soriot - Chief Executive | For |
| 5c | Re-elect Aradhana Sarin - Executive Director | For |
| 5d | Re-elect Philip Broadley - Senior Independent Director | Oppose |
| 5e | Re-elect Euan Ashley - Non-Executive Director | For |
| 5f | Re-elect Birgit Conix - Non-Executive Director | For |
| 5g | Re-elect Rene Haas - Non-Executive Director | For |
| 5h | Re-elect Karen Knudsen - Non-Executive Director | For |
| 5i | Re-elect Diana Layfield - Non-Executive Director | For |
| 5j | Re-elect Anna Manz - Non-Executive Director | For |
| 5k | Re-elect Sherilyn McCoy - Non-Executive Director | Oppose |
| 5l | Re-elect Tony Mok - Non-Executive Director | For |
| 5m | Re-elect Marcus Wallenberg - Non-Executive Director | Oppose |
| 6 | Approve the Remuneration Report | Oppose |
| 7 | Renewal of the AstraZeneca Performance Share Plan 2020 | Oppose |
| 8 | Approve Political Donations | For |
| 9 | Issue Shares with Pre-emption Rights | For |
| 10 | Issue Shares for Cash | For |
| 11 | Issue Shares for Cash for the Purpose of Financing an Acquisition or Other Capital Investment | For |
| 12 | Authorise Share Repurchase | For |
| 13 | Meeting Notification-related Proposal | For |
